Evaluation of a Neurokinin-1 Receptor –Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging

ConclusionThe excellent tumor contrast afforded by our NK1R-targeted radioimaging agent exhibits properties that could improve early diagnosis and staging of many neuroendocrine tumors.

Source: Molecular Imaging and Biology - March 10, 2020 Category: Molecular Biology Source Type: research